Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR882 Phase 2b Study in Gout
NCT05119686Phase 2Completed
- Sponsor
- Arthrosi Therapeutics
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of pozdeutinurad in gout, sponsored by Arthrosi Therapeutics. Started Nov 2021; status: completed.
02
Drugs
pozdeutinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT05119686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05119686.